Benefit and cost of repeating a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) polymerase chain reaction (PCR) test after the second day of hospitalization in five hospitals during various community prevalences and vaccination rates. (16th June 2022)

• Record Type: Journal Article
• Authors: Bulnes, Rene; Said, Mina; Bronstein, Melissa; Gutowski, Jennifer; Alag, Karan; Bress, Jonathan; Dellefave, Amber; Riedy, Dawn; Alcantara, Jose; Bhavsar, Hiloni; Gargano, Bryan; Lesho, Emil
• Is Part Of: Infection control and hospital epidemiology. Volume 44:Number 1(2023)
• Page Start: 106
• Page End: 109
• Publication Date: 2022-06-16
• Subjects: Nosocomial infections -- Epidemiology -- Periodicals; Health facilities -- Sanitation -- Periodicals; Hospital buildings -- Sanitation -- Periodicals; Cross Infection -- Periodicals; Epidemiology -- Periodicals; Hospitals -- Periodicals; Infection Control -- Periodicals; 614.44
• DOI: 10.1017/ice.2022.157
• Languages: English
• ISSNs: 0899-823X

Abstract

Abstract: At our hospital, universal severe acute respiratory coronavirus virus 2 (SARS-CoV-2) polymerase chain reaction (PCR) testing was performed upon admission and again after 2 inpatient days. As community-wide prevalence, admission, and vaccination rates varied, the number needed to benefit fluctuated between 16 and 769 and the cost per additional detection fluctuated between $800 and $29, 400. These 2 metrics were negatively associated with new hospital admissions. No other community indicator was associated with the number needed to benefit and cost per additional detection.